IL222277A0 - Pharmaceutical compositions highly dosed with biotin - Google Patents

Pharmaceutical compositions highly dosed with biotin

Info

Publication number: IL222277A0
Authority: IL; Israel
Prior art keywords: biotin; pharmaceutical compositions; compositions highly; highly dosed; dosed
Prior art date: 2010-04-06

Application number

IL222277A

Other versions

IL222277B (en

Original Assignee

Assist Publ Hopitaux De Paris

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-04-06

Filing date

2012-10-09

Publication date

2012-12-31

2012-10-09 Application filed by Assist Publ Hopitaux De Paris filed Critical Assist Publ Hopitaux De Paris

2012-12-31 Publication of IL222277A0 publication Critical patent/IL222277A0/en

2018-06-28 Publication of IL222277B publication Critical patent/IL222277B/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Medicinal Preparation (AREA)

IL222277A 2010-04-06 2012-10-09 Pharmaceutical compositions highly dosed with biotin IL222277B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR1052589A FR2958166B1 (en)	2010-04-06	2010-04-06	PHARMACEUTICAL COMPOSITIONS HIGHLY DOSE IN BIOTIN
PCT/EP2011/055273 WO2011124571A1 (en)	2010-04-06	2011-04-05	Pharmaceutical compositions highly dosed with biotin

Publications (2)

Publication Number	Publication Date
IL222277A0 true IL222277A0 (en)	2012-12-31
IL222277B IL222277B (en)	2018-06-28

Family

ID=42651240

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL222277A IL222277B (en)	2010-04-06	2012-10-09	Pharmaceutical compositions highly dosed with biotin

Country Status (17)

Country	Link
US (1)	US20130084334A1 (en)
EP (1)	EP2555771B1 (en)
CA (1)	CA2795465C (en)
CY (1)	CY1118967T1 (en)
DK (1)	DK2555771T3 (en)
ES (1)	ES2613977T3 (en)
FR (1)	FR2958166B1 (en)
HR (1)	HRP20170172T1 (en)
HU (1)	HUE031767T2 (en)
IL (1)	IL222277B (en)
LT (1)	LT2555771T (en)
PL (1)	PL2555771T3 (en)
PT (1)	PT2555771T (en)
RS (1)	RS55696B1 (en)
SI (1)	SI2555771T1 (en)
SM (1)	SMT201700122B (en)
WO (1)	WO2011124571A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2993780B1 (en) *	2012-07-26	2015-02-13	Assist Publ Hopitaux De Paris	METHOD OF TREATING PLATE SCLEROSIS
WO2014177286A1 (en)	2013-04-29	2014-11-06	Assistance Publique - Hopitaux De Paris	Biotin for use in treating x-linked adrenoleukodystrophy
EP3072513A1 (en)	2015-03-26	2016-09-28	Medday	Biotin for treating Amyotrophic lateral sclerosis
EP3275439A1 (en)	2016-07-29	2018-01-31	Medday Pharmaceuticals	Method for treating hepatic encephalopathy
CN113827591B (en) *	2021-11-09	2023-06-09	上海市肺科医院	Application of biotin in preparation of medicines for treating sepsis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0995448A (en) *	1995-09-29	1997-04-08	Calpis Food Ind Co Ltd:The	Increase in biotin concentration in blood and biotin-containing beverage or food product
US5789401A (en) *	1997-08-08	1998-08-04	Nutrition 21	High-dose chromium/biotin treatment of type II diabetes
JP2005536543A (en) *	2002-08-23	2005-12-02	ディーエスエムアイピーアセッツビー．ブイ．	Novel dietary supplement composition containing biotin
WO2004028523A1 (en) *	2002-09-30	2004-04-08	Daiichi Pharmaceutical Co., Ltd.	Particulate product comprising pantethine
IL162288A0 (en) *	2004-06-01	2005-11-20	Future Products Man S A	Compositions and methods for treating neurodegenerative disorders
US8609165B1 (en) *	2009-07-02	2013-12-17	E5 Llc	Dietary supplement for optimizing glucose levels, increasing energy, and improving general health
FR2993780B1 (en) *	2012-07-26	2015-02-13	Assist Publ Hopitaux De Paris	METHOD OF TREATING PLATE SCLEROSIS

2010
- 2010-04-06 FR FR1052589A patent/FR2958166B1/en not_active Expired - Fee Related
2011
- 2011-04-05 PT PT117142521T patent/PT2555771T/en unknown
- 2011-04-05 PL PL11714252T patent/PL2555771T3/en unknown
- 2011-04-05 SI SI201131092A patent/SI2555771T1/en unknown
- 2011-04-05 RS RS20170135A patent/RS55696B1/en unknown
- 2011-04-05 EP EP11714252.1A patent/EP2555771B1/en active Active
- 2011-04-05 CA CA2795465A patent/CA2795465C/en not_active Expired - Fee Related
- 2011-04-05 ES ES11714252.1T patent/ES2613977T3/en active Active
- 2011-04-05 WO PCT/EP2011/055273 patent/WO2011124571A1/en active Application Filing
- 2011-04-05 HU HUE11714252A patent/HUE031767T2/en unknown
- 2011-04-05 LT LTEP11714252.1T patent/LT2555771T/en unknown
- 2011-04-05 DK DK11714252.1T patent/DK2555771T3/en active
- 2011-04-05 US US13/639,752 patent/US20130084334A1/en not_active Abandoned
2012
- 2012-10-09 IL IL222277A patent/IL222277B/en active IP Right Grant
2017
- 2017-02-02 HR HRP20170172TT patent/HRP20170172T1/en unknown
- 2017-02-22 SM SM201700122T patent/SMT201700122B/en unknown
- 2017-02-22 CY CY20171100241T patent/CY1118967T1/en unknown

Also Published As

Publication number	Publication date
FR2958166A1 (en)	2011-10-07
DK2555771T3 (en)	2017-02-13
PT2555771T (en)	2017-01-17
WO2011124571A1 (en)	2011-10-13
CY1118967T1 (en)	2018-01-10
HRP20170172T1 (en)	2017-04-07
US20130084334A1 (en)	2013-04-04
SMT201700122B (en)	2017-03-08
RS55696B1 (en)	2017-07-31
LT2555771T (en)	2017-04-10
CA2795465C (en)	2018-10-30
EP2555771B1 (en)	2016-11-23
IL222277B (en)	2018-06-28
CA2795465A1 (en)	2011-10-13
SI2555771T1 (en)	2017-03-31
ES2613977T3 (en)	2017-05-29
EP2555771A1 (en)	2013-02-13
PL2555771T3 (en)	2017-07-31
FR2958166B1 (en)	2012-07-13
HUE031767T2 (en)	2017-07-28

Legal Events

Date	Code	Title	Description
2018-10-31	FF	Patent granted
2018-10-31	KB20	Patent renewed for 20 years

Publication	Publication Date	Title
HK1246170A1 (en)	2018-09-07	Pharmaceutical composition
ZA201300458B (en)	2013-09-25	C-met-modulator pharmaceutical compositions
ZA201301766B (en)	2016-11-30	Pharmaceutical compositions
IL225457A0 (en)	2013-06-27	Pharmaceutical composition
LT2619182T (en)	2017-01-25	Pharmaceutical composition
ZA201300718B (en)	2013-08-28	Pharmaceutical compositions
ZA201207670B (en)	2013-05-29	Pharmaceutical compositions
PT2579858E (en)	2014-07-18	Ivabradine-containing pharmaceutical composition
ZA201301920B (en)	2013-10-30	Pharmaceutical composition
ZA201303223B (en)	2014-01-29	Pharmaceutical compositions
GB201010453D0 (en)	2010-08-04	Pharmaceutical composition
IL222277A0 (en)	2012-12-31	Pharmaceutical compositions highly dosed with biotin
ZA201303177B (en)	2018-12-19	Pharmaceutical compositions
GB201001911D0 (en)	2010-03-24	Pharmaceutical composition
EP2560678A4 (en)	2013-09-18	Pharmaceutical compositions
ZA201303732B (en)	2018-12-19	Pharmaceutical compositions
GB201008590D0 (en)	2010-07-07	Pharmaceutical compositions
GB201019775D0 (en)	2011-01-05	Pharmaceutical composition